Five Oceans Advisors’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $194K | Buy |
12,521
+241
| +2% | +$3.73K | 0.08% | 183 |
|
|
2025
Q1 | $183K | Sell |
12,280
-6,222
| -34% | -$92.5K | 0.09% | 171 |
|
|
2024
Q4 | $245K | Buy |
18,502
+3,364
| +22% | +$44.5K | 0.11% | 131 |
|
|
2024
Q3 | $215K | Hold |
15,138
| – | – | 0.1% | 173 |
|
|
2024
Q2 | $196K | Sell |
15,138
-582
| -4% | -$7.53K | 0.1% | 166 |
|
|
2024
Q1 | $218K | Hold |
15,720
| – | – | 0.11% | 170 |
|
|
2023
Q4 | $224K | Sell |
15,720
-2,708
| -15% | -$38.6K | 0.13% | 147 |
|
|
2023
Q3 | $285K | Sell |
18,428
-2,075
| -10% | -$32.1K | 0.18% | 100 |
|
|
2023
Q2 | $322K | Hold |
20,503
| – | – | 0.21% | 91 |
|
|
2023
Q1 | $338K | Hold |
20,503
| – | – | 0.22% | 94 |
|
|
2022
Q4 | $320K | Hold |
20,503
| – | – | 0.22% | 95 |
|
|
2022
Q3 | $266K | Buy |
20,503
+5,799
| +39% | +$75.2K | 0.21% | 97 |
|
|
2022
Q2 | $206K | Buy |
14,704
+2,120
| +17% | +$29.7K | 0.15% | 114 |
|
|
2022
Q1 | $180K | Buy |
+12,584
| New | +$180K | 0.16% | 113 |
|